Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 359,429 | 294,978 | 101,716 | 17,265 | 7,753 |
| Cost of Goods | 74,075 | 51,772 | 26,261 | 7,717 | 4,057 |
| Gross Profit | 285,354 | 243,206 | 75,455 | 9,548 | 3,696 |
| Operating Expenses | 18,507 | 18,069 | 12,193 | 7,625 | 5,667 |
| Operating Income | 266,922 | 225,909 | 63,523 | 2,640 | -1,914 |
| Other Income | 282 | -1,031 | -2,359 | 82 | -8 |
| Pre-tax Income | 267,204 | 224,878 | 61,164 | 2,722 | -1,922 |
| Income Tax | 66,513 | 58,571 | 14,526 | -599 | 34 |
| Net Income Continuous | 200,691 | 166,307 | 46,638 | 3,321 | -1,956 |
| Net Income | $200,691 | $166,307 | $46,638 | $3,321 | $-1,956 |
| EPS Basic Total Ops | 6.96 | 7.27 | 2.11 | 0.15 | -0.09 |
| EPS Basic Continuous Ops | 6.96 | 7.27 | 2.11 | 0.15 | -0.09 |
| EPS Diluted Total Ops | 6.52 | 6.88 | 1.98 | 0.14 | -0.09 |
| EPS Diluted Continuous Ops | 6.52 | 6.87 | 1.98 | 0.14 | -0.09 |
| EBITDA(a) | $270,147 | $227,561 | $64,354 | $3,302 | $-1,240 |